Cumulative meta-analysis of epidermal growth factor receptor-tyrosine kinase inhibitors as first-line therapy in metastatic non-small-cell lung cancer
Sávia Raquel Costa Normando(Fundação do ABC), Auro del Giglio(Faculdade de Medicina do ABC), Felipe Melo Cruz(Instituto Brasileiro de Controle do Câncer)
Cited by 21
Related Papers
Methylene blue in photodynamic therapy: From basic mechanisms to clinical applications
|Photodiagnosis and Photodynamic Therapy|2005|910
Pembrolizumab plus chemotherapy versus placebo plus chemotherapy for HER2-negative advanced gastric cancer (KEYNOTE-859): a multicentre, randomised, double-blind, phase 3 trial
|The Lancet Oncology|2023|663
Niraparib and Abiraterone Acetate for Metastatic Castration-Resistant Prostate Cancer
|Journal of Clinical Oncology|2023|332
The biology of cancer-related fatigue: a review of the literature
|Supportive Care in Cancer|2015|305
Cancer-related fatigue: a practical review
|Annals of Oncology|2011|220